<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04605289</url>
  </required_header>
  <id_info>
    <org_study_id>17102019</org_study_id>
    <nct_id>NCT04605289</nct_id>
  </id_info>
  <brief_title>Levels of Matrix Metalloproteinase-8 After Intrapocket Treatment in Moderate Periodontitis Patients.</brief_title>
  <acronym>MMP-8</acronym>
  <official_title>Biochemical Efficacy of Cymbopogon Citratus Gel as Local Drug Delivery Agent in Reducing Matrix Metalloproteinase-8 Levels Intra-crevicularly in Moderate Periodontitis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using local delivery drugs as adjunctive to scaling and root planing and evaluating gingival&#xD;
      crevicular fluid (GCF) biological molecular markers (MMP-8).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study sample and setting A sample size of twenty patients per group (number of groups = 2)&#xD;
      (total sample size = 40 patients) is the sufficient required sample as statistically&#xD;
      significant with 80% power. The sample size was calculated using g power version 3.1.9.2.&#xD;
      patients will be recruited from the outpatient clinic of the Department of Oral Medicine,&#xD;
      Periodontology, Diagnosis and Oral Radiology. Faculty of Dentistry, Alexandria University.&#xD;
&#xD;
      Treatment will be in accordance with the principles of the modified Helsinki code for human&#xD;
      clinical studies (2013).&#xD;
&#xD;
      The clinical study will be conducted following the ethical guidelines for conduct of research&#xD;
      on human subjects, by the Faculty of Dentistry, Alexandria University (IRB NO:00010556 - IORG&#xD;
      0008839).&#xD;
&#xD;
      Data management and statistical analysis The data will be processed and analysed using&#xD;
      statistical package for social sciences program SPSS (20.0) software*. The study will include&#xD;
      descriptive and analytical data. A P-value of less than 0.05 will be considered statistically&#xD;
      significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 13, 2020</start_date>
  <completion_date type="Actual">October 14, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>-Cymbopogon citratus oil gel /-Placebo gel. will be intrapocket application as an adjunctive treatment to conventional therapy</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of clinical attachment and periodontal probing pocket</measure>
    <time_frame>at baseline and twelve weeks from intervention.</time_frame>
    <description>Millimeters (mm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GCF concentration of MMP-8</measure>
    <time_frame>at baseline, one week, and twelve weeks from intervention.</time_frame>
    <description>pg/ml</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Group I (study group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Scaling and root planing + intra-pocket application of 2% Cymbopogon citratus (lemon-grass) gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (control group)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Scaling and root planing +intra-pocket application of placebo gel</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lemongrass essential oil gel</intervention_name>
    <description>The lemongrass oil gel will be administered by means of a syringe with a bent, blunt-end needle. The needle will be carefully inserted into the periodontal pocket and the gel will be applied in the test sites in a gentle probing manner, attempting to fill the full extent of the pocket. The gel will be applied up to the gingival margin and the excess gel will be removed with sterile gauze.&#xD;
Periodontal dressing will be applied after the delivery of the drug, and they will be also asked not to eat for thirty minutes.&#xD;
After placement of the gel in situ, patients will be instructed to follow strict oral hygiene protocol and not chew hard or sticky foods at the gel placement sites for rest of the week.</description>
    <arm_group_label>Group I (study group)</arm_group_label>
    <other_name>Cymbopogon citratus oil gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo will be administered by means of a syringe with a bent, blunt-end needle. The needle will be carefully inserted into the periodontal pocket and the gel will be applied in the test sites in a gentle probing manner, attempting to fill the full extent of the pocket. The gel will be applied up to the gingival margin and the excess gel will be removed with sterile gauze.&#xD;
Periodontal dressing will be applied after the delivery of the drug, and they will be also asked not to eat for thirty minutes.&#xD;
After placement of the gel in situ, patients will be instructed to follow strict oral hygiene protocol and not chew hard or sticky foods at the gel placement sites for rest of the week.</description>
    <arm_group_label>Group II (control group)</arm_group_label>
    <other_name>Carbopol®-Based pH-Sensitive gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and root planing</intervention_name>
    <description>Conventional mechanical treatment by ultra-sonic scalers</description>
    <arm_group_label>Group I (study group)</arm_group_label>
    <arm_group_label>Group II (control group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients of both sexes having moderate periodontitis (stage II), CAL 3-4mm.&#xD;
&#xD;
          2. Patients' age between 25 and 45 years old.&#xD;
&#xD;
          3. Systemically healthy patients.&#xD;
&#xD;
          4. No history of periodontal therapy (surgical and non-surgical) or taken any antibiotic&#xD;
             therapy for the past six months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of smoking.&#xD;
&#xD;
          2. Patients having previous adverse reaction to the products (or similar products) used&#xD;
             in this study.&#xD;
&#xD;
          3. Grade C category that has rapid rate of progression.&#xD;
&#xD;
          4. Pregnant and lactating women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadein E Sharif</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alexandria University</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Bascones-Martínez A, Muñoz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain C, Campo-Trapero J. Host defence mechanisms against bacterial aggression in periodontal disease: Basic mechanisms. Med Oral Patol Oral Cir Bucal. 2009 Dec 1;14(12):e680-5. Review.</citation>
    <PMID>19680192</PMID>
  </reference>
  <reference>
    <citation>Preshaw M. Periodontal disease pathogenesis. 13th ed. Newman M, Takei H, Klokkevold P, Carranza F, editors. Philadelphia: Elsevier - Health Sciences Division; 2018.</citation>
  </reference>
  <reference>
    <citation>Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018 Jun;45 Suppl 20:S1-S8. doi: 10.1111/jcpe.12935.</citation>
    <PMID>29926489</PMID>
  </reference>
  <reference>
    <citation>Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol. 2018 Jun;45 Suppl 20:S149-S161. doi: 10.1111/jcpe.12945. Review. Erratum in: J Clin Periodontol. 2019 Jul;46(7):787.</citation>
    <PMID>29926495</PMID>
  </reference>
  <reference>
    <citation>Needleman I, Garcia R, Gkranias N, Kirkwood KL, Kocher T, Iorio AD, Moreno F, Petrie A. Mean annual attachment, bone level, and tooth loss: A systematic review. J Clin Periodontol. 2018 Jun;45 Suppl 20:S112-S129. doi: 10.1111/jcpe.12943.</citation>
    <PMID>29926483</PMID>
  </reference>
  <reference>
    <citation>Taba M Jr, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am. 2005 Jul;49(3):551-71, vi. Review.</citation>
    <PMID>15978241</PMID>
  </reference>
  <reference>
    <citation>Hernández-Ríos P, Hernández M, Garrido M, Tervahartiala T, Leppilahti J, Kuula H, et al. Oral fluid matrix metalloproteinase (MMP)-8 as a diagnostic tool in chronic periodontitis. Dove Press. 2016; 2016(30):11-18.</citation>
  </reference>
  <reference>
    <citation>Goodson JM. Diagnosis of Periodontitis by Physical Measurement: Interpretation From Episodic Disease Hypothesis. J Periodontol. 1992 Apr;63 Suppl 4S:373-382. doi: 10.1902/jop.1992.63.4s.373.</citation>
    <PMID>29539683</PMID>
  </reference>
  <reference>
    <citation>Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000. 2003;31:32-42. Review.</citation>
    <PMID>12656994</PMID>
  </reference>
  <reference>
    <citation>Kinney JS, Morelli T, Braun T, Ramseier CA, Herr AE, Sugai JV, Shelburne CE, Rayburn LA, Singh AK, Giannobile WV. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res. 2011 Jun;90(6):752-8. doi: 10.1177/0022034511399908. Epub 2011 Mar 15. Erratum in: J Dent Res. 2011 Aug;90(8):1037.</citation>
    <PMID>21406610</PMID>
  </reference>
  <reference>
    <citation>Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, Giannobile WV. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol. 2014 Feb;41(2):113-120. doi: 10.1111/jcpe.12194. Epub 2013 Dec 12.</citation>
    <PMID>24303954</PMID>
  </reference>
  <reference>
    <citation>Wilton JM, Curtis MA, Gillett IR, Griffiths GS, Maiden MF, Sterne JA, Wilson DT, Johnson NW. Detection of high-risk groups and individuals for periodontal diseases: laboratory markers from analysis of saliva. J Clin Periodontol. 1989 Sep;16(8):475-83. Review.</citation>
    <PMID>2674204</PMID>
  </reference>
  <reference>
    <citation>Srivastava N, Nayak PA, Rana S. Point of Care- A Novel Approach to Periodontal Diagnosis-A Review. J Clin Diagn Res. 2017 Aug;11(8):ZE01-ZE06. doi: 10.7860/JCDR/2017/26626.10411. Epub 2017 Aug 1. Review.</citation>
    <PMID>28969294</PMID>
  </reference>
  <reference>
    <citation>Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol 2000. 2006;42:180-218. Review.</citation>
    <PMID>16930311</PMID>
  </reference>
  <reference>
    <citation>Aimetti M. Nonsurgical periodontal treatment. Int J Esthet Dent. 2014 Summer;9(2):251-67. Review.</citation>
    <PMID>24765632</PMID>
  </reference>
  <reference>
    <citation>Zandbergen D, Slot DE, Cobb CM, Van der Weijden FA. The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol. 2013 Mar;84(3):332-51. doi: 10.1902/jop.2012.120040. Epub 2012 May 21. Review.</citation>
    <PMID>22612369</PMID>
  </reference>
  <reference>
    <citation>Tariq M, Iqbal Z, Ali J, Baboota S, Talegaonkar S, Ahmad Z, Sahni JK. Treatment modalities and evaluation models for periodontitis. Int J Pharm Investig. 2012 Jul;2(3):106-22. doi: 10.4103/2230-973X.104394.</citation>
    <PMID>23373002</PMID>
  </reference>
  <reference>
    <citation>Sethi K, Kale A, Mahale S, Karde P, Mamajiwala A, Sonawane S. Comparative evaluation of clinical and microbiological efficacy of 2% lemongrass gel versus 1%chlorhexidine gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized controlled clinical trial. Int J Adv Res. 2018; 6(7):381-388.</citation>
  </reference>
  <reference>
    <citation>Moro MG, Silveira Souto ML, Franco GCN, Holzhausen M, Pannuti CM. Efficacy of local phytotherapy in the nonsurgical treatment of periodontal disease: A systematic review. J Periodontal Res. 2018 Jun;53(3):288-297. doi: 10.1111/jre.12525. Epub 2018 Jan 19.</citation>
    <PMID>29352465</PMID>
  </reference>
  <reference>
    <citation>Bhat G, Kudva P, Dodwad V. Aloe vera: Nature's soothing healer to periodontal disease. J Indian Soc Periodontol. 2011 Jul;15(3):205-9. doi: 10.4103/0972-124X.85661.</citation>
    <PMID>22028505</PMID>
  </reference>
  <reference>
    <citation>Grover S, Tewari S, Sharma RK, Singh G, Yadav A, Naula SC. Effect of Subgingivally Delivered 10% Emblica officinalis Gel as an Adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis - A Randomized Placebo-controlled Clinical Trial. Phytother Res. 2016 Jun;30(6):956-62. doi: 10.1002/ptr.5600. Epub 2016 Feb 24.</citation>
    <PMID>26914986</PMID>
  </reference>
  <reference>
    <citation>Phogat M, Rana T, Prasad N, Baiju CS. Comparative evaluation of subgingivally delivered xanthan-based chlorhexidine gel and herbal extract gel in the treatment of chronic periodontitis. J Indian Soc Periodontol. 2014 Mar;18(2):172-7. doi: 10.4103/0972-124X.131319.</citation>
    <PMID>24872624</PMID>
  </reference>
  <reference>
    <citation>Warad SB, Kolar SS, Kalburgi V, Kalburgi NB. Lemongrass essential oil gel as a local drug delivery agent for the treatment of periodontitis. Anc Sci Life. 2013 Apr;32(4):205-11. doi: 10.4103/0257-7941.131973.</citation>
    <PMID>24991068</PMID>
  </reference>
  <reference>
    <citation>Jayasinha P. Lemongrass. In. Colombo: Industrial Technology Institute; 1999. 1-45.</citation>
  </reference>
  <reference>
    <citation>Souza Formigoni ML, Lodder HM, Gianotti Filho O, Ferreira TM, Carlini EA. Pharmacology of lemongrass (Cymbopogon citratus Stapf). II. Effects of daily two month administration in male and female rats and in offspring exposed &quot;in utero&quot;. J Ethnopharmacol. 1986 Jul;17(1):65-74.</citation>
    <PMID>3762196</PMID>
  </reference>
  <reference>
    <citation>Leite JR, Seabra Mde L, Maluf E, Assolant K, Suchecki D, Tufik S, Klepacz S, Calil HM, Carlini EA. Pharmacology of lemongrass (Cymbopogon citratus Stapf). III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans. J Ethnopharmacol. 1986 Jul;17(1):75-83.</citation>
    <PMID>2429120</PMID>
  </reference>
  <reference>
    <citation>Choudhury S. Effect of clipping height on herb and essential oil yield of Cymbopogon. Indian J Agron. 1994;39(4):592-598</citation>
  </reference>
  <reference>
    <citation>Manvitha K, Bidya B. Review on pharmacological activity of cymbopogon citratus. Int. J. Herb. Med. 2014;1(6): 5-7.</citation>
  </reference>
  <reference>
    <citation>Mulyaningsih S, Sporer F, Reichling J, Wink M. Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens. Pharm Biol. 2011 Sep;49(9):893-9. doi: 10.3109/13880209.2011.553625. Epub 2011 May 19.</citation>
    <PMID>21591991</PMID>
  </reference>
  <reference>
    <citation>Sadlon AE, Lamson DW. Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices. Altern Med Rev. 2010 Apr;15(1):33-47. Review.</citation>
    <PMID>20359267</PMID>
  </reference>
  <reference>
    <citation>Ghosh G. Traditional use of plants against leprosy in India: a review of the recent literature. J Innov Pharm Biol Sci. 2017;4(4): 55-64.</citation>
  </reference>
  <reference>
    <citation>Silva-Néto RP, Peres MF, Valença MM. Odorant substances that trigger headaches in migraine patients. Cephalalgia. 2014 Jan;34(1):14-21. doi: 10.1177/0333102413495969. Epub 2013 Jul 5.</citation>
    <PMID>23832131</PMID>
  </reference>
  <reference>
    <citation>Arrey Tarkang P, Franzoi KD, Lee S, Lee E, Vivarelli D, Freitas-Junior L, Liuzzi M, Nolé T, Ayong LS, Agbor GA, Okalebo FA, Guantai AN. In vitro antiplasmodial activities and synergistic combinations of differential solvent extracts of the polyherbal product, Nefang. Biomed Res Int. 2014;2014:835013. doi: 10.1155/2014/835013. Epub 2014 Apr 27.</citation>
    <PMID>24877138</PMID>
  </reference>
  <reference>
    <citation>Arrey Tarkang P, Nwachiban Atchan AP, Kuiate JR, Okalebo FA, Guantai AN, Agbor GA. Antioxidant potential of a polyherbal antimalarial as an indicator of its therapeutic value. Adv Pharmacol Sci. 2013;2013:678458. doi: 10.1155/2013/678458. Epub 2013 Dec 19.</citation>
    <PMID>24454347</PMID>
  </reference>
  <reference>
    <citation>Figueirinha A, Francisco V, Costa G, Liberal J, Lopes M, García-Rodríguez C, et al. Chemical characterization and anti-inflammatory activity of luteolin glycosides isolated from lemongrass. J Funct Foods. 2014;10(2):436-443</citation>
  </reference>
  <reference>
    <citation>Francisco V, Costa G, Figueirinha A, Marques C, Pereira P, Miguel Neves B, Celeste Lopes M, García-Rodríguez C, Teresa Cruz M, Teresa Batista M. Anti-inflammatory activity of Cymbopogon citratus leaves infusion via proteasome and nuclear factor-κB pathway inhibition: contribution of chlorogenic acid. J Ethnopharmacol. 2013 Jun 21;148(1):126-34. doi: 10.1016/j.jep.2013.03.077. Epub 2013 Apr 10.</citation>
    <PMID>23583902</PMID>
  </reference>
  <reference>
    <citation>Meenapriya M, Priya J. Effects of lemongrass oil on rheumatoid arthritis. J Pharm Sci &amp; Res. 2017;9(2): 237-239.</citation>
  </reference>
  <reference>
    <citation>de Cássia da Silveira e Sá R, Andrade LN, de Sousa DP. A review on anti-inflammatory activity of monoterpenes. Molecules. 2013 Jan 18;18(1):1227-54. doi: 10.3390/molecules18011227. Review.</citation>
    <PMID>23334570</PMID>
  </reference>
  <reference>
    <citation>Anand M, Goyal R, Bhat S, Kamath S, Aggarwal M, Bhandarkar M, et al. A novel anti-oxidant lemon grass oil mouth wash-a clinical trial. J Exp Biol Sci. 2011;2(3): 59-64.</citation>
  </reference>
  <reference>
    <citation>Kumar S, Gurunathan D. Lemongrass in dental health. Drug Invention Today. 2019;11(3): 780-785.</citation>
  </reference>
  <reference>
    <citation>Prabahar C, Nivetha R. Evaluation of efficacy of lemongrass gel as a local drug delivery with chlorhexidine gel in chronic periodontitis -a comparative study. Int J Adv Res. 2017;6(9): 6017-6020.</citation>
  </reference>
  <reference>
    <citation>Kumar S, Himmelstein KJ. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci. 1995 Mar;84(3):344-8.</citation>
    <PMID>7616375</PMID>
  </reference>
  <reference>
    <citation>Gul SS, Griffiths GS, Stafford GP, Al-Zubidi MI, Rawlinson A, Douglas CWI. Investigation of a Novel Predictive Biomarker Profile for the Outcome of Periodontal Treatment. J Periodontol. 2017 Nov;88(11):1135-1144. doi: 10.1902/jop.2017.170187. Epub 2017 Jul 3.</citation>
    <PMID>28671508</PMID>
  </reference>
  <reference>
    <citation>Nędzi-Góra M, Górska R, Kostrzewa-Janicka J, Kowalski J. Concentration of MMP-8 and IL-1β in gingival crevicular fluid in patients with chronic and aggressive periodontitis. Cent Eur J Immunol. 2017;42(4):342-346. doi: 10.5114/ceji.2017.72824. Epub 2017 Dec 30.</citation>
    <PMID>29472810</PMID>
  </reference>
  <reference>
    <citation>Buduneli N, Kinane DF. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol. 2011 Mar;38 Suppl 11:85-105. doi: 10.1111/j.1600-051X.2010.01670.x. Review.</citation>
    <PMID>21323706</PMID>
  </reference>
  <reference>
    <citation>Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004 Nov;10(6):311-8. Review.</citation>
    <PMID>15533204</PMID>
  </reference>
  <reference>
    <citation>Reinhardt RA, Stoner JA, Golub LM, Lee HM, Nummikoski PV, Sorsa T, Payne JB. Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis. J Periodontol. 2010 Feb;81(2):251-9. doi: 10.1902/jop.2009.090374.</citation>
    <PMID>20151804</PMID>
  </reference>
  <reference>
    <citation>Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869.</citation>
    <PMID>20332511</PMID>
  </reference>
  <reference>
    <citation>Christodoulides N, Nikolidakis D, Chondros P, Becker J, Schwarz F, Rössler R, Sculean A. Photodynamic therapy as an adjunct to non-surgical periodontal treatment: a randomized, controlled clinical trial. J Periodontol. 2008 Sep;79(9):1638-44. doi: 10.1902/jop.2008.070652 .</citation>
    <PMID>18771363</PMID>
  </reference>
  <reference>
    <citation>Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91.</citation>
    <PMID>17695343</PMID>
  </reference>
  <reference>
    <citation>Ismail FA, Napaporn J, Hughes JA, Brazeau GA. In situ gel formulations for gene delivery: release and myotoxicity studies. Pharm Dev Technol. 2000;5(3):391-7.</citation>
    <PMID>10934739</PMID>
  </reference>
  <reference>
    <citation>Kim J, Shin W. How to do random allocation (randomization). Clin Orthop Surg. 2014 Mar;6(1):103-9. doi: 10.4055/cios.2014.6.1.103. Epub 2014 Feb 14.</citation>
    <PMID>24605197</PMID>
  </reference>
  <reference>
    <citation>Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.</citation>
    <PMID>20332509</PMID>
  </reference>
  <reference>
    <citation>Lenox JA, Kopczyk RA. A clinical system for scoring a patient's oral hygiene performance. J Am Dent Assoc. 1973 Apr;86(4):849-52.</citation>
    <PMID>4511175</PMID>
  </reference>
  <reference>
    <citation>Glavind L, Löe H. Errors in the clinical assessment of periodontal destruction. J Periodontal Res. 1967;2(3):180-4.</citation>
    <PMID>4237475</PMID>
  </reference>
  <reference>
    <citation>Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967 Nov-Dec;38(6):Suppl:610-6.</citation>
    <PMID>5237684</PMID>
  </reference>
  <reference>
    <citation>Azouni KG, Tarakji B. The trimeric model: a new model of periodontal treatment planning. J Clin Diagn Res. 2014 Jul;8(7):ZE17-20. doi: 10.7860/JCDR/2014/8458.4623. Epub 2014 Jul 20. Review.</citation>
    <PMID>25177662</PMID>
  </reference>
  <reference>
    <citation>Do J, Takei H, Carranza F. The Treatment Plan. In Newman M, Takei H, Klokkevold P, Carranza F. Newman and Carranza's Clinical Periodontology. 13th ed. Philadelphia: Elsevier - Health Sciences Division; 2018. 426-430.</citation>
  </reference>
  <reference>
    <citation>Goodson J. Intra-pocket drug delivery devices for treatment of periodontal. U.S. Patent. 1988.</citation>
  </reference>
  <reference>
    <citation>Guentsch A, Kramesberger M, Sroka A, Pfister W, Potempa J, Eick S. Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis. J Periodontol. 2011 Jul;82(7):1051-60. doi: 10.1902/jop.2011.100565. Epub 2011 Jan 14.</citation>
    <PMID>21235330</PMID>
  </reference>
  <reference>
    <citation>Kinane DF, Darby IB, Said S, Luoto H, Sorsa T, Tikanoja S, Mäntylä P. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res. 2003 Aug;38(4):400-4.</citation>
    <PMID>12828657</PMID>
  </reference>
  <reference>
    <citation>World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.</citation>
    <PMID>24141714</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2020</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Nadein El Sharif</investigator_full_name>
    <investigator_title>A student of Master's degree</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all collected IPD</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 17, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT04605289/Prot_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

